about
GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients by developing a practice-changing treatment for depression. Its initial focus is on developing novel and proprietary mebufotenin therapies f...
Read More
28.71
-0.42
(-1.44%)
637.5K
XNAS Volume
XNAS 17 Jul, 2026 5:30 PM (EDT)
Not Eligible
Expensive Valuation
Technically Bullish
GH Research PLC Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..